Clonal evolution and immune evasion in posttransplantation relapses.

Area of Science:

• Hematology
• Immunology
• Evolutionary Biology

Background:

• Allogeneic hematopoietic cell transplantation (allo-HCT) has improved for hematological malignancies.
• Disease relapse remains a significant challenge with limited salvage options.

Observation:

• Relapses often result from evolutionary processes selecting for resistant disease variants.
• Changes in clonal structure and immunogenicity are observed at relapse.

Findings:

• Mechanisms include clonal evolution, immune checkpoint enforcement, and HLA alterations.
• Disease tropism for privileged sites can facilitate relapse.
• These mechanisms interact in complex patterns.

Implications:

• Understanding relapse mechanisms is crucial for personalized therapeutic strategies.
• Targeting evolutionary dynamics may improve allo-HCT outcomes.
• Further research into combined mechanisms can guide future treatments.